Preliminary Results – Analysts’ Meeting and Webcast on Monday, 19 November 2018

31 Oct 2018

Monday, 19 November 2018

Redx Pharma (AIM: REDX), the drug development company focused on cancer and fibrosis, will announce its preliminary results for the year ended 30 September 2018 on Monday 19 November 2018.

Lisa Anson, Chief Executive Officer, would like to invite you to an analyst meeting at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD at 9.30am GMT with registration and coffee from 9.15am GMT.

Please could you let me know if you or a colleague would like to attend by calling me on 0203 727 1366 or return email to Mary.whittow@fticonsulting.com.